Vertex Pharmaceuticals Incorporated
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Last updated:
Abstract:
Compounds of Formula I: ##STR00001## pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
Status:
Grant
Type:
Utility
Filling date:
4 Dec 2019
Issue date:
30 Nov 2021